January 04, 2023
Semi-protecting Semiconductors Poses a Risk to National Security
When it comes to semiconductors, protectionism is alive in the omnibus spending bill that Congress passed in December. Whether it is strengthening supply chain protections against major Chinese semiconductor companies or appropriating long-awaited domestic manufacturing incentive programs included in the CHIPS and Science Act, the United States has committed to restoring America’s edge on its shores.
As the United States makes significant investments in semiconductor manufacturing as a long-term solution, it cannot forgo its existing strengths.
Washington’s latest action signals another step toward reversing decades of globalization rooted in economics rather than national security. It recognizes that a specialized supply chain is only more cost-effective until relationships become reliance, as is the concern with Taiwan Semiconductor Manufacturing Company (TSMC), which alone produces about 50 percent of the world’s semiconductors.
Read the full article from The Hill.
More from CNAS
-
Biotech Matters: Public-Private Coordination of Biotechnology
An appreciation of biotechnology’s great opportunities is, for many commentators, intimately joined with regret about a disconnect between the U.S. government and the private ...
By Richard Danzig
-
$6.6 billion TSMC deal in Arizona the latest in the CHIPS Act’s rollout
“President Biden signed the CHIPS and Science Act just about 20 months ago, which in government time is yesterday. And they’ve hired 200 people,” said Vivek Chilukuri, a senio...
By Vivek Chilukuri
-
Response to NTIA Request for Comment: “Dual Use Foundation Artificial Intelligence Models with Widely Available Model Weights”
In February 2024, the Department of Commerce’s National Telecommunications and Information Administration (NTIA) issued a Request for Comment (RFC) on the implications of “ope...
By Caleb Withers
-
Biotech Matters: Great Data Competition and Interoperability with Allies and Partners
Understanding and strengthening America’s biotechnology leadership requires exploring the limits of existing data relevant to the U.S. bioeconomy so that policymakers and the ...
By Michelle Holko